[Antihistaminics. Side effects also after raising dosage at the placebo level].
出版信息
MMW Fortschr Med. 2003 May 29;145(22):50-1.
PMID:12866280
Abstract
摘要
相似文献
1
[Antihistaminics. Side effects also after raising dosage at the placebo level].
MMW Fortschr Med. 2003 May 29;145(22):50-1.
2
[In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med. 2003 May 29;145(22):51.
3
Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
J Allergy Clin Immunol. 1998 May;101(5):638-45. doi: 10.1016/S0091-6749(98)70172-1.
4
[Peripheral anticholinergic syndrome].
Rev Alerg Mex. 2007 Mar-Apr;54(2):66-9.
5
Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
Clin Ther. 2000 May;22(5):573-82. doi: 10.1016/S0149-2918(00)80045-4.
6
[Respiratory allergies in the child and the adult].
Rev Prat. 2004 Jan 31;54(2):189-98.
7
[Oral second generation antihistamines in allergic rhinitis].
Laryngorhinootologie. 2005 Jan;84(1):30-41. doi: 10.1055/s-2004-826000.
8
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Ann Allergy Asthma Immunol. 2002 Feb;88(2):190-7. doi: 10.1016/S1081-1206(10)61995-3.
9
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Clin Exp Allergy. 2009 Sep;39(9):1338-47. doi: 10.1111/j.1365-2222.2009.03257.x. Epub 2009 May 4.
10
Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Ann Allergy Asthma Immunol. 2002 Sep;89(3):304-10. doi: 10.1016/S1081-1206(10)61959-X.
Zotero 插件